Study on the expression of lactate transport-related proteins in follicular lymphoma and their relationship with clinicopathologic features

Objective: To investigate the expression of the lactate transport-related proteins MCT1, MCT4, and their chaperone CD147 in follicular lymphoma (FL), and to delineate their potential correlations with clinicopathological parameters predictive of prognosis. Methods: Immunohistochemistry was employed to evaluate the expression of MCT1, MCT4, and CD147 in tumor cells. Associations between protein expression and clinicopathological variables relevant to patient outcome were statistically analyzed. Results: 1. MCT1-positive immunoreactivity was significantly associated with elevated serum β2-microglobulin (β2-M, a small circulating protein that rises with disease activity and serves as a marker of tumor load and adverse outcomes in lymphomas) level, male sex, and Ki-67 ≥ 30%; MCT4-positive immunoreactivity was significantly associated with Ki-67 ≥ 30%; CD147-positive immunoreactivity correlated significantly with low-grade FL. 2. Four distinct expression patterns of MCT1/MCT4 were identified: double-positive, double-negative, MCT1-positive only, and MCT4-positive only. High-grade FL demonstrated a significant predilection for either double-positive or single-positive expression; Ki-67 < 30% was significantly linked to the double-negative expression; elevated serum β2-M was significantly associated with MCT1-positive only expression; age ≥60 years and female sex were significantly associated with MCT4-positive only expression. Conclusion: The expression of MCT1, MCT4, and CD147 in FL is correlated with adverse clinicopathological features, thereby furnishing additional evidence for refinement of the Follicular Lymphoma International Prognostic Index (FLIPI, a five-parameter clinical score predicting outcome in newly diagnosed follicular lymphoma). Targeted inhibition of MCT1 and MCT4 may represent a novel therapeutic strategy. Furthermore, the heterogeneous expression of these three proteins suggests metabolic heterogeneity within FL, offering a mechanistic basis for future investigations.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-04-13
DOI
https://doi.org/10.3389/fcell.2026.1697031
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study on the expression of lactate transport-related proteins in follicular lymphoma and their relationship with clinicopathologic features

Xueju Wang, Xuemei Wang, Zheng Xu, Jiuling Li et al.
Frontiers in Cell and Developmental Biology
Lymphoma Diagnosis and Treatment
article

Study on the expression of lactate transport-related proteins in follicular lymphoma and their relationship with clinicopathologic features

Xueju Wang, Xuemei Wang, Zheng Xu, Jiuling Li, Xin Zhang
article en

Abstract

Objective: To investigate the expression of the lactate transport-related proteins MCT1, MCT4, and their chaperone CD147 in follicular lymphoma (FL), and to delineate their potential correlations with clinicopathological parameters predictive of prognosis. Methods: Immunohistochemistry was employed to evaluate the expression of MCT1, MCT4, and CD147 in tumor cells. Associations between protein expression and clinicopathological variables relevant to patient outcome were statistically analyzed. Results: 1. MCT1-positive immunoreactivity was significantly associated with elevated serum β2-microglobulin (β2-M, a small circulating protein that rises with disease activity and serves as a marker of tumor load and adverse outcomes in lymphomas) level, male sex, and Ki-67 ≥ 30%; MCT4-positive immunoreactivity was significantly associated with Ki-67 ≥ 30%; CD147-positive immunoreactivity correlated significantly with low-grade FL. 2. Four distinct expression patterns of MCT1/MCT4 were identified: double-positive, double-negative, MCT1-positive only, and MCT4-positive only. High-grade FL demonstrated a significant predilection for either double-positive or single-positive expression; Ki-67 < 30% was significantly linked to the double-negative expression; elevated serum β2-M was significantly associated with MCT1-positive only expression; age ≥60 years and female sex were significantly associated with MCT4-positive only expression. Conclusion: The expression of MCT1, MCT4, and CD147 in FL is correlated with adverse clinicopathological features, thereby furnishing additional evidence for refinement of the Follicular Lymphoma International Prognostic Index (FLIPI, a five-parameter clinical score predicting outcome in newly diagnosed follicular lymphoma). Targeted inhibition of MCT1 and MCT4 may represent a novel therapeutic strategy. Furthermore, the heterogeneous expression of these three proteins suggests metabolic heterogeneity within FL, offering a mechanistic basis for future investigations.

Frontiers in Cell and Developmental BiologyVol. 14
Union Hospital (HK), Union Hospital (CN)
Natural Science Foundation of Jilin Province, People's Government of Jilin Province, Education Department of Jilin Province, National Science and Technology Major Project, Wu Jieping Medical Foundation, National Key Research and Development Program of China
Openalex Percentile: Top 27%
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.